{"id":"https://openalex.org/W2915150892","doi":"https://doi.org/10.1182/blood-2018-99-116434","title":"Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)","display_name":"Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2915150892","doi":"https://doi.org/10.1182/blood-2018-99-116434","mag":"2915150892"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-116434","doi":"https://doi.org/10.1182/blood-2018-99-116434","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-116434","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071582835","display_name":"Samuel D. Slavin","orcid":"https://orcid.org/0000-0002-7208-1351","observed_orcids":["https://orcid.org/0000-0002-7208-1351"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Samuel Slavin","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009387581","display_name":"Andrew Mark Brunner","orcid":"https://orcid.org/0000-0002-2169-4115","observed_orcids":["https://orcid.org/0000-0002-2169-4115"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew M. Brunner","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090527595","display_name":"David P. Steensma","orcid":"https://orcid.org/0000-0001-5130-9284","observed_orcids":["https://orcid.org/0000-0001-5130-9284"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Steensma","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010057352","display_name":"Amir Tahmasb Fathi","orcid":"https://orcid.org/0000-0003-4907-6447","observed_orcids":["https://orcid.org/0000-0003-4907-6447"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir T. Fathi","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047939331","display_name":"Martha Wadleigh","orcid":"https://orcid.org/0000-0002-8191-1708","observed_orcids":["https://orcid.org/0000-0002-8191-1708"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Wadleigh","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065595440","display_name":"Gabriela Soriano Hobbs","orcid":"https://orcid.org/0000-0002-0199-9333","observed_orcids":["https://orcid.org/0000-0002-0199-9333"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela S. Hobbs","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009091754","display_name":"Philip C. Amrein","orcid":"https://orcid.org/0000-0001-7770-2623","observed_orcids":["https://orcid.org/0000-0001-7770-2623"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip C. Amrein","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009871897","display_name":"Jennifer S. Temel","orcid":"https://orcid.org/0000-0002-7268-5921","observed_orcids":["https://orcid.org/0000-0002-7268-5921"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer S Temel","raw_affiliation_strings":["Hematology-Oncology, Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology, Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091710463","display_name":"Gregory Alan Abel","orcid":"https://orcid.org/0000-0003-1100-2813","observed_orcids":["https://orcid.org/0000-0003-1100-2813"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory A. Abel","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078852708","display_name":"Areej R El-Jawahri","orcid":"https://orcid.org/0000-0002-3556-1495","observed_orcids":["https://orcid.org/0000-0002-3556-1495"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Areej El-Jawahri","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5009871897","https://openalex.org/A5071582835"],"corresponding_institution_ids":["https://openalex.org/I4210087915"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"4750","last_page":"4750"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10177","display_name":"Palliative Care and End-of-Life Issues","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.9049999713897705},{"id":"https://openalex.org/keywords/intensive-care-unit-admission","display_name":"intensive care unit admission","score":0.9359999895095825},{"id":"https://openalex.org/keywords/icu-mortality","display_name":"ICU mortality","score":0.8149999976158142},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.9369999766349792},{"id":"https://openalex.org/keywords/functional-recovery","display_name":"functional recovery","score":0.6880000233650208},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.9710000157356262},{"id":"https://openalex.org/keywords/vasopressors","display_name":"vasopressors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/invasive-mechanical-ventilation","display_name":"invasive mechanical ventilation","score":0.921999990940094},{"id":"https://openalex.org/keywords/renal-replacement-therapy","display_name":"renal replacement therapy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/risk-factors-for-mortality","display_name":"mortality risk factors","score":0.765999972820282},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6320000290870667},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.4970000088214874},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.4169999957084656},{"id":"https://openalex.org/keywords/health-care-access","display_name":"health care access","score":0.3440000116825104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9320858716964722},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.686747670173645},{"id":"https://openalex.org/C2777080012","wikidata":"https://www.wikidata.org/wiki/Q3766250","display_name":"Mechanical ventilation","level":2,"score":0.4983940124511719},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4818619191646576},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.47688132524490356},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4717070758342743},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.4573895037174225},{"id":"https://openalex.org/C2776888751","wikidata":"https://www.wikidata.org/wiki/Q767485","display_name":"Respiratory failure","level":2,"score":0.4384320378303528},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4234955310821533},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36028552055358887},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3421434164047241},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3271949291229248}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-116434","doi":"https://doi.org/10.1182/blood-2018-99-116434","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-116434","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2960420612","https://openalex.org/W2583963566","https://openalex.org/W4406106775","https://openalex.org/W2557120254","https://openalex.org/W2173061072","https://openalex.org/W2026174447","https://openalex.org/W4401592268","https://openalex.org/W2553697828","https://openalex.org/W3166902050","https://openalex.org/W1789365696"],"abstract_inverted_index":{"Abstract":[0],"Introductions:":[1],"Older":[2],"adults":[3],"with":[4,32,55,82,129,306,327,340,345,367,379],"acute":[5],"myeloid":[6],"leukemia":[7],"(AML)":[8],"have":[9,26],"been":[10,27],"shown":[11],"to":[12,35,48,62,111,136,261,274,353],"experience":[13],"high":[14],"health":[15],"care":[16],"utilization":[17],"including":[18],"ICU":[19,59,66,102,120,151,185,218,229,275,331,343,354,394],"admissions.":[20],"While":[21],"risk":[22,113],"factors":[23,114],"for":[24,29,115,150,251,359],"mortality":[25,118,329],"identified":[28],"younger":[30],"patients":[31,44,54,77,128,169,183,200,221,339,378],"AML":[33,56,83,130,341],"admitted":[34,135],"the":[36,50,137,194,357],"ICU,":[37],"less":[38],"is":[39],"known":[40],"about":[41],"how":[42],"older":[43,53,338,377],"fare.":[45],"We":[46,69,93,107],"sought":[47],"examine":[49],"outcomes":[51],"of":[52,65,74,96,125,168,182,199,241,254,284,309,320,337],"following":[57,330],"an":[58,233],"admission,":[60,186],"and":[61,86,98,162,187,212,258,282,318,356],"identify":[63,112],"predictors":[64],"mortality.":[67,311,370],"Methods:":[68],"conducted":[70],"a":[71,266],"retrospective":[72],"analysis":[73],"330":[75],"consecutive":[76],"\u2265":[78,131],"60":[79,132],"years":[80,133],"diagnosed":[81],"between":[84],"2005":[85],"2011":[87],"at":[88,203,225,245],"two":[89,285,360,386],"hospitals":[90],"in":[91],"Boston.":[92],"examined":[94],"rates":[95],"survival":[97],"functional":[99,347],"recovery":[100],"after":[101,119,217],"admissions":[103],"using":[104],"descriptive":[105],"statistics.":[106],"used":[108],"logistic":[109],"regression":[110],"higher":[116,269,368],"in-hospital":[117,310,328,369],"admission.":[121,219,332,395],"Results:":[122],"A":[123,196,334],"total":[124],"96/330":[126],"(29.1%)":[127],"were":[134,153,190,201,223,249,304,324,365],"ICU.":[138],"The":[139,146],"median":[140],"age":[141],"was":[142],"67":[143],"(range":[144],"60-88).":[145],"most":[147],"common":[148],"reasons":[149],"admission":[152,276,344,355],"respiratory":[154],"failure":[155,160],"(38.7%),":[156],"shock":[157],"(36.6%),":[158],"multi-organ":[159],"(8.6%),":[161],"intracranial":[163],"hemorrhage":[164],"(4.3%).":[165],"Approximately":[166],"half":[167],"required":[170],"vasopressors":[171],"(46.9%,":[172],"45/96)":[173],"or":[174,243,286,361,387],"invasive":[175,292],"ventilation":[176],"(47.9%,":[177],"46/96).":[178],"Overall,":[179],"57.3%":[180],"(55/96)":[181],"survived":[184],"45.8%":[188],"(44/96)":[189],"eventually":[191],"discharged":[192],"from":[193,316,393],"hospital.":[195],"substantial":[197,335],"minority":[198],"alive":[202,224],"30":[204],"days":[205,209,227],"(42.7%,":[206],"41/96),":[207],"90":[208,226],"(35.4%,":[210],"34/96),":[211],"one":[213],"year":[214],"(30.2%,":[215],"29/96)":[216],"Among":[220],"who":[222,382],"post":[228],"stay,":[230],"76.0%":[231],"had":[232],"Eastern":[234],"Cooperative":[235],"Oncology":[236],"Group":[237],"(ECOG)":[238],"performance":[239,271,350],"status":[240,272,351],"0":[242],"1":[244],"that":[246,374],"time;":[247],"74.9%":[248],"independent":[250],"all":[252],"activities":[253],"daily":[255],"living":[256],"(ADLs),":[257],"78.6%":[259],"continued":[260],"receive":[262],"AML-directed":[263],"therapy.":[264],"In":[265],"multivariate":[267],"analysis,":[268],"ECOG":[270],"prior":[273,352],"(OR":[277],"2.52,":[278],"P":[279,301],"=":[280,299],"0.026),":[281],"receipt":[283,319],"more":[287,362,388],"life-support":[288],"modalities":[289],"(i.e.":[290],"vasopressors,":[291],"ventilation,":[293],"and/or":[294],"renal":[295],"replacement":[296],"therapy;":[297],"OR":[298],"14.3,":[300],"<":[302],"0.001)":[303],"associated":[305,326,366],"increased":[307],"odds":[308],"Age,":[312],"comorbidities,":[313],"gender,":[314],"time":[315],"diagnosis,":[317],"stem":[321],"cell":[322],"transplantation":[323],"not":[325,384],"Conclusions:":[333],"proportion":[336],"survive":[342],"excellent":[346],"outcomes.":[348],"Poorer":[349],"need":[358],"life-sustaining":[363,389],"therapies":[364],"These":[371],"data":[372],"suggest":[373],"critically":[375],"ill":[376],"AML-especially":[380],"those":[381],"do":[383],"require":[385],"therapies-often":[390],"ultimately":[391],"benefit":[392],"Disclosures":[396],"Brunner:":[397],"Takeda:":[398,429,446],"Research":[399,403,406,410,421,437,442,450,465],"Funding;":[400,404,411,422,438,443,451],"Celgene:":[401,418],"Consultancy,":[402,416,419,427,430,449,453,458,462],"Novartis:":[405],"Funding.":[407,466],"Fathi:Agios:":[408],"Honoraria,":[409,420,436],"Astellas:":[412],"Honoraria;":[413,417,424,428,433,447,454,459],"Boston":[414],"Biomedical:":[415],"Jazz:":[423],"Seattle":[425],"Genetics:":[426],"Honoraria.":[431,463],"DeAngelo:Shire:":[432],"Blueprint":[434],"Medicines:":[435],"BMS:":[439],"Consultancy;":[440,445],"Glycomimetics:":[441],"Amgen:":[444],"ARIAD:":[448],"Incyte:":[452],"Novartis":[455],"Pharmaceuticals":[456],"Corporation:":[457],"Pfizer":[460],"Inc:":[461],"Amrein:Takeda:":[464]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-03-02T00:00:00"}